CORBF (Global Cord Blood) ROCE %: 7.28% (As of Mar. 2022)


CORBF Global Cord Blood Corp CORBF
12 GF Score
Price $0.95
View Full Analysis

What is Global Cord Blood ROCE %?

Global Cord Blood CORBF 12 ROCE % is 7.28% as of Mar. 2022. GuruFocus rates CORBF with a GF Score™ of 12/100.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Global Cord Blood's annualized ROCE % for the quarter that ended in Mar. 2022 was 7.28%.

Global Cord Blood  (OTCPK:CORBF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Global Cord Blood ROCE % Related Terms

Global Cord Blood ROCE % Historical Data

* Premium members only.

The historical data trend for Global Cord Blood's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Global Cord Blood ROCE % Chart

Global Cord Blood Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.97 6.54 8.68 8.10 8.13

Global Cord Blood Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.25 8.56 8.50 7.85 7.28
CORBF
12GF Score
Global Cord Blood Corp CORBF
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Global Cord Blood ROCE % Calculation

Global Cord Blood's annualized ROCE % for the fiscal year that ended in Mar. 2022 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2022 )  (A: Mar. 2021 )(A: Mar. 2022 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2022 )  (A: Mar. 2021 )(A: Mar. 2022 )
=95.966/( ( (1214.322 - 96.218) + (1345.164 - 101.907) )/ 2 )
=95.966/( (1118.104+1243.257)/ 2 )
=95.966/1180.6805
=8.13 %

Global Cord Blood's ROCE % of for the quarter that ended in Mar. 2022 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2022 )  (Q: Dec. 2021 )(Q: Mar. 2022 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2022 )  (Q: Dec. 2021 )(Q: Mar. 2022 )
=89.612/( ( (1318.469 - 99.932) + (1345.164 - 101.907) )/ 2 )
=89.612/( ( 1218.537 + 1243.257 )/ 2 )
=89.612/1230.897
=7.28 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2022) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 7.28% mean?
Global Cord Blood (CORBF) has a ROCE % of 7.28% as of Mar. 2022.
Is Global Cord Blood's ROCE % too high?
Global Cord Blood's current ROCE % is 7.28%. Overall, Global Cord Blood has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Global Cord Blood's ROCE % compare to PRE and LMDX?
Global Cord Blood's ROCE % of 7.28% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Diagnostics & Research company?
A good ROCE % depends on the Medical Diagnostics & Research industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Global Cord Blood's current ROCE % is 7.28%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Global Cord Blood stock overvalued right now?
Global Cord Blood (CORBF) has a current ROCE % of 7.28%. The current ROCE % is 7.28%. Global Cord Blood's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Global Cord Blood (CORBF), the current ROCE % is 7.28% as of Mar. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Global Cord Blood Business Description

Address 1 Garden Road, 48th Floor, Bank of China Tower, Central, Hong Kong, HKG
Global Cord Blood Corp provides cord blood banking services. The company provides cord blood processing and storage services for expectant parents interested in capturing the evolving medical treatments and technologies such as cord blood transplants. The company generates all of its revenues by providing subscribers with processing services, which consist of the testing and processing of cord blood units, and storage services, which consist of the storage of cord blood units in its facilities.
12GF Score

Get the complete analysis for CORBF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.95
Price